These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 20370697)

  • 1. Mechanisms of resistance to antimicrobial drugs in pathogenic Gram-positive cocci.
    Mlynarczyk B; Mlynarczyk A; Kmera-Muszynska M; Majewski S; Mlynarczyk G
    Mini Rev Med Chem; 2010 Sep; 10(10):928-37. PubMed ID: 20370697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of the resistance and tolerance to beta-lactam and glycopeptide antibiotics in pathogenic gram-positive cocci.
    Mlynarczyk A; Mlynarczyk B; Kmera-Muszynska M; Majewski S; Mlynarczyk G
    Mini Rev Med Chem; 2009 Nov; 9(13):1527-37. PubMed ID: 20205634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological counterstrike: antibiotic resistance mechanisms of Gram-positive cocci.
    Woodford N
    Clin Microbiol Infect; 2005 May; 11 Suppl 3():2-21. PubMed ID: 15811020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survey of blood stream infections attributable to gram-positive cocci: frequency of occurrence and antimicrobial susceptibility of isolates collected in 1997 in the United States, Canada, and Latin America from the SENTRY Antimicrobial Surveillance Program. SENTRY Participants Group.
    Pfaller MA; Jones RN; Doern GV; Sader HS; Kugler KC; Beach ML
    Diagn Microbiol Infect Dis; 1999 Apr; 33(4):283-97. PubMed ID: 10212756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A study of in vitro activity of daptomycin against 2679 Gram-positive cocci].
    Zhang FF; Zhao CJ; Wang ZW; Liu WY; Yan W; Peng QS; Jiang S; Guo Y; Liu JB; Chen HB; Li HN; Wang Q; Wang H
    Zhonghua Nei Ke Za Zhi; 2013 Jun; 52(6):474-9. PubMed ID: 24059993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Macrolides, lincosamides, streptogramines (MLS): mechanisms of action and resistance].
    Ungureanu V
    Bacteriol Virusol Parazitol Epidemiol; 2010; 55(2):131-8. PubMed ID: 21553477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Problems with antimicrobial resistance in gram-positive cocci.
    Moellering RC
    Clin Infect Dis; 1998 May; 26(5):1177-8. PubMed ID: 9597248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activities of clindamycin, synercid, telithromycin, linezolid, and mupirocin against Gram-positive coccal strains resistant to erythromycin in Korea.
    Kwon AR; Yoon EJ; Yoon JM; Kim H; Shim MJ; Choi EC
    Arch Pharm Res; 2007 Jul; 30(7):840-3. PubMed ID: 17703735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activity of linezolid against Gram-positive cocci possessing genes conferring resistance to protein synthesis inhibitors.
    Fines M; Leclercq R
    J Antimicrob Chemother; 2000 Jun; 45(6):797-802. PubMed ID: 10837432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial susceptibility of gram-positive bacteria isolated from European medical centres: results of the Daptomycin Surveillance Programme (2002-2004).
    Sader HS; Streit JM; Fritsche TR; Jones RN
    Clin Microbiol Infect; 2006 Sep; 12(9):844-52. PubMed ID: 16882289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activity of daptomycin against Gram-positive cocci: the first multicentre study in Greece.
    Malli E; Spiliopoulou I; Kolonitsiou F; Klapsa D; Giannitsioti E; Pantelidi K; Pratti A; Panopoulou M; Grapsa S; Alepopoulou E; Neonakis I; Frantzidou F; Alexiou-Daniel S; Bakola D; Koutsia-Carouzou C; Malamou-Lada H; Zerva L; Vlahaki E; Kartali-Ktenidou S; Anastassiou ED; Petinaki E
    Int J Antimicrob Agents; 2008 Dec; 32(6):525-8. PubMed ID: 18774268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the in vitro activity of daptomycin against 19615 clinical isolates of Gram-positive cocci collected in North American hospitals (2002-2005).
    Pfaller MA; Sader HS; Jones RN
    Diagn Microbiol Infect Dis; 2007 Apr; 57(4):459-65. PubMed ID: 17240105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multicenter evaluation of linezolid antimicrobial activity in North America.
    Ballow CH; Jones RN; Biedenbach DJ;
    Diagn Microbiol Infect Dis; 2002 May; 43(1):75-83. PubMed ID: 12052632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Linezolid in vitro: mechanism and antibacterial spectrum.
    Livermore DM
    J Antimicrob Chemother; 2003 May; 51 Suppl 2():ii9-16. PubMed ID: 12730138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macrolide resistance mechanisms in Gram-positive cocci.
    Pechère JC
    Int J Antimicrob Agents; 2001; 18 Suppl 1():S25-8. PubMed ID: 11574191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimicrobial susceptibility of 3931 organisms isolated from intensive care units in Canada: Canadian National Intensive Care Unit Study, 2005/2006.
    Zhanel GG; DeCorby M; Nichol KA; Wierzbowski A; Baudry PJ; Karlowsky JA; Lagacé-Wiens P; Walkty A; Mulvey MR; Hoban DJ;
    Diagn Microbiol Infect Dis; 2008 Sep; 62(1):67-80. PubMed ID: 18513913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial-Resistance Genetic Markers in Potentially Pathogenic Gram Positive Cocci Isolated from Brazilian Soft Cheese.
    Resende JA; Fontes CO; Ferreira-Machado AB; Nascimento TC; Silva VL; Diniz CG
    J Food Sci; 2018 Feb; 83(2):377-385. PubMed ID: 29337343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Daptomycin susceptibility of 833 strains of Gram-positive cocci from a university hospital in Japan (2009-2011).
    Yoshizumi A; Ishii Y; Iwata M; Murakami H; Yumoto S; Yasui K; Maehara C; Fukuzawa S; Enokizono K; Tateda K
    Diagn Microbiol Infect Dis; 2014 Oct; 80(2):151-3. PubMed ID: 25056827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibiotic therapeutic options for infections caused by drug-resistant Gram-positive cocci.
    Banwan K; Senok AC; Rotimi VO
    J Infect Public Health; 2009; 2(2):62-73. PubMed ID: 20701863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiologic trends in nosocomial and community-acquired infections due to antibiotic-resistant gram-positive bacteria: the role of streptogramins and other newer compounds.
    Jones RN; Low DE; Pfaller MA
    Diagn Microbiol Infect Dis; 1999 Feb; 33(2):101-12. PubMed ID: 10091033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.